ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
2,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,4,Serum sickness,Allergic conditions NEC,Allergic conditions,Immun,N
3,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
4,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
5,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
5,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
